Xylem revenue and financials
In the fiscal year ended December 2025, Xylem reported revenue of $9.04B (+5.52% year over year). Net income was $957M, a net margin of 10.6%.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +5.52%
- 2025 vs 2024
- Net income growth
- +7.53%
- 2025 vs 2024
- Net margin
- 10.6%
- 2024: 10.4%
How Xylem is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 13.1% a year on average over the last 5 years
Compound annual growth rate: from $4.88B in 2020 to $9.04B in 2025.
Revenue has grown for 5 fiscal years in a row
Each fiscal year compared with the one before, up to 2025.
Operating margin rose from 11.3% to 13.5%
Operating income over revenue, 2022 → 2025: 2.3 percentage points.
Profits turn into cash: free cash flow equal to 97% of net income
Totals for fiscal years 2023–2025: free cash flow $2.38B, net income $2.46B.
Shares outstanding up 34.7% in 5 years
Average diluted shares, 2020 → 2025: with more shares, each one represents a smaller stake in the company (dilution).
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 9,035 | 8,562 | 7,364 | 5,522 | 5,195 | 4,876 | 5,249 | 5,207 | 4,707 | 3,771 |
| Cost of revenue | 5,560 | 5,350 | 4,647 | 3,438 | 3,220 | 3,046 | 3,203 | 3,181 | 2,860 | 2,309 |
| Gross profit | 3,475 | 3,212 | 2,717 | 2,084 | 1,975 | 1,830 | 2,046 | 2,026 | 1,847 | 1,462 |
| Selling, general and administrative | 1,930 | 1,915 | 1,760 | 1,227 | 1,193 | 1,158 | 1,165 | 1,150 | 1,086 | 895 |
| Research and development | 226 | 230 | 232 | 206 | 204 | 187 | 191 | 189 | 181 | 110 |
| Operating income | 1,223 | 1,009 | 652 | 622 | 585 | 367 | 486 | 654 | 552 | 408 |
| EBIT | 1,319 | 1,067 | 725 | 651 | 578 | 485 | 690 | 687 | 580 | 486 |
| EBITDA | 1,894 | 1,629 | 1,161 | 890 | 824 | 736 | 947 | 948 | 814 | 637 |
| Interest expense | 29.0 | 44.0 | 49.0 | 50.0 | 76.0 | 77.0 | 67.0 | 82.0 | 82.0 | 70.0 |
| Pre-tax income | 1,181 | 1,087 | 635 | 440 | 511 | 285 | 416 | 585 | 466 | 340 |
| Income tax | 231 | 197 | 26.0 | 85.0 | 84.0 | 31.0 | 15.0 | 36.0 | 136 | 80.0 |
| Net income | 957 | 890 | 609 | 355 | 427 | 254 | 401 | 549 | 331 | 260 |
| Net income to common shareholders | 957 | 890 | 609 | 355 | 427 | 254 | 401 | 549 | 331 | 260 |
| Basic EPS | 3.93 | 3.67 | 2.81 | 1.97 | 2.37 | 1.41 | 2.23 | 3.05 | 1.84 | 1.45 |
| Diluted EPS | 3.92 | 3.65 | 2.79 | 1.96 | 2.35 | 1.40 | 2.21 | 3.03 | 1.83 | 1.45 |
| Average shares (basic) | 243 | 243 | 217 | 180 | 180 | 180 | 180 | 180 | 180 | 179 |
| Average shares (diluted) | 244 | 244 | 218 | 181 | 182 | 181 | 181 | 181 | 181 | 180 |
| Dividend per share | 1.60 | 1.44 | 1.32 | 1.20 | 1.12 | 1.04 | 0.96 | 0.84 | 0.72 | 0.62 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2,201 | 2,336 | 2,125 | 2,397 | 2,268 | 2,301 | 2,069 | 2,256 | 2,104 | 2,169 | 2,033 | 2,118 |
| Cost of revenue | 1,333 | 1,377 | 1,322 | 1,465 | 1,385 | 1,409 | 1,301 | 1,399 | 1,320 | 1,350 | 1,281 | 1,362 |
| Gross profit | 868 | 959 | 803 | 932 | 883 | 892 | 768 | 857 | 784 | 819 | 752 | 756 |
| Selling, general and administrative | 461 | 503 | 473 | 489 | 476 | 504 | 461 | 509 | 445 | 486 | 475 | 331 |
| Research and development | 56.0 | 59.0 | 56.0 | 60.0 | 52.0 | 58.0 | 56.0 | 58.0 | 55.0 | 58.0 | 59.0 | 60.0 |
| Operating income | 351 | 397 | 274 | 383 | 355 | 330 | 251 | 290 | 284 | 275 | 218 | 365 |
| EBIT | 351 | 397 | 274 | 383 | 355 | 330 | 251 | 290 | 284 | 275 | 218 | 365 |
| EBITDA | 488 | 537 | 414 | 526 | 497 | 475 | 396 | 432 | 425 | 420 | 352 | 502 |
| Interest expense | 21.0 | 7.0 | 4.0 | 6.0 | 6.0 | 9.0 | 8.0 | 9.0 | 10.0 | 11.0 | 14.0 | 14.0 |
| Pre-tax income | 365 | 364 | 244 | 368 | 297 | 299 | 217 | 375 | 269 | 247 | 196 | 210 |
| Income tax | 77.0 | 103 | 55.0 | 35.0 | 71.0 | 75.0 | 50.0 | 49.0 | 52.0 | 53.0 | 43.0 | -56.0 |
| Net income | 291 | 263 | 193 | 335 | 227 | 226 | 169 | 326 | 217 | 194 | 153 | 266 |
| Net income to common shareholders | 291 | 263 | 193 | 335 | 227 | 226 | 169 | 326 | 217 | 194 | 153 | 266 |
| Basic EPS | 1.25 | 1.11 | 0.79 | 1.38 | 0.93 | 0.93 | 0.70 | 1.34 | 0.89 | 0.80 | 0.63 | 1.10 |
| Diluted EPS | 1.25 | 1.11 | 0.79 | 1.37 | 0.93 | 0.93 | 0.69 | 1.33 | 0.89 | 0.80 | 0.63 | 1.10 |
| Average shares (basic) | 233 | 236 | 243 | 244 | 243 | 243 | 243 | 243 | 243 | 243 | 242 | 241 |
| Average shares (diluted) | 233 | 237 | 243 | 244 | 244 | 244 | 244 | 244 | 244 | 244 | 243 | 242 |
| Dividend per share | 0.43 | 0.43 | 0.43 | 0.40 | 0.40 | 0.40 | 0.40 | 0.36 | 0.36 | 0.36 | 0.36 | 0.33 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 17,634 | 16,493 | 16,112 | 7,952 | 8,276 | 8,750 | 7,710 | 7,222 | 6,860 | 6,474 |
| Current assets | 4,641 | 4,098 | 3,884 | 3,012 | 3,160 | 3,523 | 2,450 | 2,094 | 2,071 | 1,839 |
| Cash and equivalents | 1,479 | 1,121 | 1,019 | 944 | 1,349 | 1,875 | 724 | 296 | 414 | 308 |
| Receivables | 1,759 | 1,668 | 1,617 | 1,096 | 953 | 923 | 1,036 | 1,031 | 956 | 843 |
| Inventory | 983 | 996 | 1,018 | 799 | 700 | 558 | 539 | 595 | 524 | 522 |
| Net property, plant and equipment | 1,668 | 1,558 | 1,602 | 940 | 948 | 929 | 899 | 656 | 643 | 616 |
| Goodwill | 8,332 | 7,980 | 7,587 | 2,719 | 2,792 | 2,854 | 2,839 | 2,976 | 2,768 | 2,632 |
| Other intangible assets | 2,272 | 2,379 | 2,529 | 930 | 1,016 | 1,093 | 1,174 | 1,232 | 1,168 | 1,201 |
| Current liabilities | 2,856 | 2,336 | 2,205 | 1,590 | 1,391 | 1,956 | 1,501 | 1,389 | 1,100 | 1,238 |
| Accounts payable | 1,013 | 1,006 | 968 | 723 | 639 | 569 | 597 | 586 | 549 | 457 |
| Long-term debt | 1,954 | 2,031 | 2,268 | 1,880 | 2,440 | 2,484 | 2,040 | 2,051 | 2,200 | 2,108 |
| Total debt | 2,475 | 2,443 | 2,726 | 2,198 | 2,752 | 2,763 | 2,286 | 2,051 | 2,200 | 2,265 |
| Total liabilities | 5,885 | 5,611 | 5,936 | 4,449 | 5,050 | 5,774 | 4,743 | 4,440 | 4,341 | 4,267 |
| Total equity (incl. minority) | 11,749 | 10,882 | 10,176 | 3,503 | 3,226 | 2,976 | 2,967 | 2,782 | 2,519 | 2,207 |
| Retained earnings | 3,706 | 3,140 | 2,601 | 2,292 | 2,154 | 1,930 | 1,866 | 1,639 | 1,227 | 1,033 |
| Minority interest | 269 | 240 | 10.0 | 9.0 | 8.0 | 8.0 | 10.0 | 14.0 | 16.0 | 17.0 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 17,326 | 17,342 | 16,954 | 17,634 | 17,295 | 17,191 | 16,559 | 16,493 | 16,046 | 15,765 | 15,924 | 16,112 |
| Current assets | 3,952 | 4,394 | 4,030 | 4,641 | 4,441 | 4,369 | 4,084 | 4,098 | 4,013 | 3,781 | 3,893 | 3,884 |
| Cash and equivalents | 708 | 1,276 | 808 | 1,479 | 1,191 | 1,170 | 1,059 | 1,121 | 989 | 815 | 947 | 1,019 |
| Receivables | 1,971 | 1,887 | 1,796 | 1,759 | 1,804 | 1,845 | 1,748 | 1,668 | 1,712 | 1,680 | 1,646 | 1,617 |
| Inventory | 1,052 | 1,016 | 991 | 983 | 1,035 | 1,071 | 1,022 | 996 | 1,091 | 1,057 | 1,039 | 1,018 |
| Net property, plant and equipment | 1,203 | 1,167 | 1,151 | 1,668 | 1,141 | 1,189 | 1,157 | 1,558 | 1,158 | 1,144 | 1,141 | 1,602 |
| Goodwill | 8,524 | 8,256 | 8,292 | 8,332 | 8,280 | 8,237 | 8,061 | 7,980 | 7,593 | 7,509 | 7,509 | 7,587 |
| Other intangible assets | 2,220 | 2,150 | 2,213 | 2,272 | 2,319 | 2,354 | 2,332 | 2,379 | 2,326 | 2,374 | 2,454 | 2,529 |
| Current liabilities | 2,842 | 2,724 | 2,755 | 2,856 | 2,269 | 2,301 | 2,166 | 2,336 | 2,052 | 2,042 | 2,331 | 2,205 |
| Accounts payable | 1,055 | 1,013 | 969 | 1,013 | 968 | 1,047 | 958 | 1,006 | 930 | 940 | 948 | 968 |
| Long-term debt | 2,365 | 2,395 | 1,407 | 1,408 | 1,913 | 1,928 | 1,974 | 1,978 | 1,977 | 1,981 | 1,985 | 2,268 |
| Total debt | 3,026 | 3,055 | 2,061 | 2,475 | 2,089 | 2,124 | 2,136 | 2,443 | 2,103 | 2,104 | 2,374 | — |
| Total liabilities | 6,815 | 6,676 | 5,725 | 5,885 | 5,850 | 5,882 | 5,505 | 5,611 | 5,446 | 5,417 | 5,721 | 5,936 |
| Total equity (incl. minority) | 10,511 | 10,666 | 11,229 | 11,749 | 11,445 | 11,309 | 11,054 | 10,882 | 10,600 | 10,348 | 10,203 | 10,176 |
| Retained earnings | 4,147 | 3,956 | 3,794 | 3,706 | 3,469 | 3,339 | 3,211 | 3,140 | 2,902 | 2,774 | 2,667 | 2,601 |
| Minority interest | 242 | 245 | 257 | 269 | 238 | 235 | 238 | 240 | 7.0 | 7.0 | 8.0 | 10.0 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1,241 | 1,263 | 837 | 596 | 538 | 824 | 839 | 586 | 686 | 497 |
| Depreciation and amortization | 575 | 562 | 436 | 236 | 245 | 251 | 257 | 261 | 234 | 151 |
| Capital expenditure | -331 | -321 | -271 | -208 | -208 | -183 | -226 | -237 | -170 | -124 |
| Investing cash flow | -471 | -482 | -628 | -191 | -183 | -169 | -231 | -643 | -181 | -1,886 |
| Financing cash flow | -501 | -615 | -157 | -790 | -855 | 473 | -177 | -40.0 | -421 | 1,034 |
| Dividends paid | -391 | -350 | -299 | -217 | -203 | -188 | -174 | -152 | -130 | -112 |
| Share repurchases | -15.0 | -20.0 | -25.0 | -52.0 | -68.0 | -61.0 | -40.0 | -59.0 | -25.0 | -4.0 |
| Debt issued | 1.0 | 1.0 | 278 | 0.0 | — | 1,344 | 281 | 336 | — | 1,814 |
| Debt repaid | -82.0 | -285 | -160 | -527 | -600 | -640 | -254 | -172 | -282 | -688 |
| Effect of exchange rates | 90.0 | -53.0 | 23.0 | -20.0 | -26.0 | 23.0 | -3.0 | -21.0 | 22.0 | -17.0 |
| Net change in cash | 358 | 102 | 75.0 | -405 | -526 | 1,151 | 428 | -118 | 106 | -372 |
| Free cash flow | 873 | 942 | 566 | 388 | 330 | — | — | — | — | — |
| Levered free cash flow | 893 | 930 | 413 | 386 | 251 | 556 | 553 | 323 | 392 | 332 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 331 | 290 | 108 | 543 | 360 | 305 | 33.0 | 575 | 311 | 288 | 89.0 | 455 |
| Depreciation and amortization | 137 | 140 | 140 | 143 | 142 | 145 | 145 | 142 | 141 | 145 | 134 | 137 |
| Capital expenditure | -89.0 | -90.0 | -91.0 | -83.0 | -79.0 | -135 | -71.0 | -100 | -74.0 | -73.0 | -74.0 | -94.0 |
| Investing cash flow | -456 | -22.0 | -76.0 | -142 | -189 | -125 | -15.0 | -289 | -65.0 | -77.0 | -51.0 | -89.0 |
| Financing cash flow | -451 | 199 | -683 | -119 | -138 | -128 | -116 | -95.0 | -101 | -337 | -82.0 | -86.0 |
| Dividends paid | -100 | -101 | -106 | -98.0 | -97.0 | -98.0 | -98.0 | -87.0 | -88.0 | -87.0 | -88.0 | -80.0 |
| Share repurchases | -337 | -680 | -563 | -1.0 | -1.0 | 0.0 | -13.0 | -1.0 | -1.0 | -3.0 | -15.0 | -15.0 |
| Debt issued | 4.0 | 990 | 0.0 | 0.0 | 4.0 | 3.0 | 1.0 | 1.0 | — | — | — | 2.0 |
| Debt repaid | -9.0 | -2.0 | -4.0 | -22.0 | -39.0 | -24.0 | -4.0 | -4.0 | -4.0 | -272 | -5.0 | -5.0 |
| Effect of exchange rates | 8.0 | -16.0 | -15.0 | 7.0 | -1.0 | 59.0 | 25.0 | -48.0 | 29.0 | -6.0 | -28.0 | 34.0 |
| Net change in cash | -568 | 468 | -671 | 288 | 21.0 | 111 | -62.0 | 132 | 174 | -132 | -72.0 | 314 |
| Free cash flow | 242 | 200 | 17.0 | 460 | 281 | 170 | -38.0 | 475 | 237 | 215 | 15.0 | 361 |
| Levered free cash flow | 259 | 373 | 70.8 | 508 | 230 | 151 | 4.9 | 541 | 199 | 207 | -16.5 | 439 |
Financial statements of similar companies
Companies in the group: same industry, similar size
